Nahdi Medical Company (TADAWUL:4164)

Saudi Arabia · Delayed Price · Currency is SAR

95.50

-0.75 (-0.78%)

Aug 13, 2026, 3:19 PM AST

-20.88% (1Y)

Market Cap	12.10B -19.1%
Revenue (ttm)	10.52B +6.5%
Net Income	788.08M -5.5%
EPS	6.06 -5.5%
Shares Out	130.00M
PE Ratio	15.35
Forward PE	14.20
Dividend	5.60 (5.86%)
Ex-Dividend Date	Aug 16, 2026

Volume	194,384
Open	95.50
Previous Close	96.25
Day's Range	95.50 - 95.50
52-Week Range	89.75 - 124.80
Beta	0.12
Analysts	Buy
Price Target	121.52 (+27.25%)
Earnings Date	Oct 29, 2026

About Nahdi Medical Company

Nahdi Medical Company, together with its subsidiaries, engages in the wholesale and retail trading of cosmetics, pharmaceutical, special and healthy foods, and medical equipment products in the Kingdom of Saudi Arabia and the United Arab Emirates. The company also offers mom and baby, beauty, and everyday essentials through retail and online stores. In addition, it operates Nahdi Care polyclinic; and provides virtual care services. Further, the company is involved in operating E-Pharmacist platform; and Nahdi Online, an online pharmacy. Additio... [Read more]

Industry Medical - Pharmaceuticals

Sector Healthcare

Founded 1986

Employees 6,182

Stock Exchange Saudi Stock Exchange

Ticker Symbol 4164

Full Company Profile

Financial Performance

In 2025, Nahdi Medical Company's revenue was 10.21 billion, an increase of 8.12% compared to the previous year's 9.45 billion. Earnings were 830.74 million, an increase of 1.22%.

Financial Statements

Analyst Summary

According to 9 analysts, the average rating for 4164 stock is "Buy." The 12-month stock price target is SAR 121.52, which is an increase of 27.25% from the latest price.

Price Target

SAR 121.52

(27.25% upside)

Analyst Consensus: Buy

Stock Forecasts